1Blackwell TS, Christman JW.The role of nuclear factor-kappa B in cytokine gene regulation.Am J Respir Cell Mol Biol,1997,17:3-9.
2Schwartz MD,Moore EE,Moore FA,et al.Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome.Crit Care Med,1996,24:1285-1292.
3Manning AM,Bell EP,Rosenbloom CL,et al.NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment.J Inflamm,1995,45:283-296.
4Blackwell TS,Blackwell TR,Holden EP,et al.In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.J Immunol,1996,157:1630-1637.
5Liu SF,Ye X,Malik AB.In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock.J Immunol,1997,159:3976-3983.
6Liu SF,Ye X,Malik AB.Inhibition of NF-kappa B activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes.Circulation,1999,100:1330-1337.
7Liu SF,Ye X,Malik AB.Pyrrolidine dithiocarbamate prevents I-kappa B degradation and reduces microvascular injury induced by lipopolysacc-haride in multiple organs.Mol Pharmacol,1999,55:658-667.
8Abraham E,Carmody A,Shenkar R,et al.Neu-trophils as early immunologic effectors in hemorrhage-or endotoxemia-induced acute lung injury.Am J Physiol Lung Cell Mol Physiol,2000,279:1137-1145.
9Parsey MV,Tuder RM,Abraham E.Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia.J Immunol,1998,160:1007-1013.
10Shenkar R,Abraham E.Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia:roles of reactive oxygen intermediates,NF-kappa B,and cyclic AMP response element binding protein.J Immunol,1999,163:954-962.
2Miller PR, Croce MA, Kilgo PD, et al. Acute respiratory distress syndrome in blunt trauma : identification of independent risk factors. Am Surg,2002,68 ( 10 ) : 845-850.
3Streetz KL, Tluedde, Mpmarms, Trautwein C. Interleukine-6 and liver regeneration. Gut,2000,47 : 309.
4Kishimoto T, Akira S, Taga T. Interleukine-6 and its receptor: A paradigm for cytokines. Science, 1992,258:593.
5Kucich V, Rosenbloom JC, Herick DJ, et al.Singaling events reguired for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts [J]. Arch Biochem Biophys, 2001,395( 1 ):103-112.
6Han S, Sidell N. RU486-induced growth inhibition of human endometrial cells involves the nuclear factor-B signaling pathway[J]. J Clini Endoerinol Metabo,2003,88(2):713-719.
7Schmitt-Graff A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity[J]. Virchows Arch,1994,425(1):3-24.
8Kelynack KJ, Hewistson TD, Pedagogos E, et al. Renal myofibroblast contract collagen I matrix lattices in vitro [J]. Am J Nephrol,1999,19 (6):694-701.
9Hashimoto S, Con Y, Takeshita I, et al. Transforming growth factorbetal induces phenotypic modulation of human lung fibroblast to myofibrohlast through a c-Jun-NH2-terminal kinase-dependent pathway[J]. Am J Respair Crit Care Med,2001,163(1): 152-157.
